Targeting mitochondria to protect axons in progressive MS
- 1 September 2019
- journal article
- review article
- Published by Elsevier in Neuroscience Letters
- Vol. 710, 134258
Abstract
No abstract availableKeywords
Funding Information
- National Multiple Sclerosis Society
- Wellcome Trust
- Multiple Sclerosis Society
This publication has 41 references indexed in Scilit:
- Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosisBrain, 2015
- Pathological mechanisms in progressive multiple sclerosisThe Lancet Neurology, 2015
- Reduced expression of PGC-1α partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortexActa Neuropathologica, 2012
- NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injuryBrain, 2012
- Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implicationsCurrent Opinion in Neurology, 2011
- Analysis of the mitochondrial proteome in multiple sclerosis cortexBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Mitochondrial DNA deletions and neurodegeneration in multiple sclerosisAnnals of Neurology, 2010
- A Gradient of neuronal loss and meningeal inflammation in multiple sclerosisAnnals of Neurology, 2010
- Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patientsAnnals of Neurology, 2006
- Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the diseaseJournal of the Neurological Sciences, 2003